Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...

Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was ...

Background von Hippel-Lindau (vHL) syndrome is a rare autosomal-dominant disorder that confers a lifelong risk for developing both benign and malignant tumours in multiple organs. Recent evidence ...

EDISON, N.J., May 11, 2026 /PRNewswire/ -- LabGenomics, a national diagnostics company specializing in advanced anatomical pathology and molecular testing, today announced that QDx Pathology Services ...

Plasma cell disorders present challenges in phenotypic determination, as they range from monoclonality of plasma cells to multiple myeloma and plasma cell leukemia. According to World Health ...

Sinn Féin housing spokesman Eoin Ó Broin is one of a number of TDs to criticise the Government for the situation Councils across the country have been running out of funding for the tenant-in-situ ...

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading provider of oncology testing services, today announced the acquisition of Pathline, LLC, a ...

The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma ...

For most types of cancer, determining the stage (extent) of the cancer is very important. The stage is based on the size of the tumor and how far the cancer has spread. This can be helpful in ...

Center for Advanced Measurement Science, National Institute of Metrology, Beijing 10002, China ...

Karen Raymaakers RN, CON(C) is a certified oncology nurse that has worked with leukemia and lymphoma patients for over a decade. Diagnosing leukemia often starts with a complete blood count (CBC) and ...